Skip to search formSkip to main contentSkip to account menu

ABT 107

Known as: ABT-107, ABT107 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice
Nicotine withdrawal produces cognitive deficits that can predict relapse. Amelioration of these cognitive deficits emerges as a… 
2015
2015
Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
2015
2015
Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with α7 nicotinic acetylcholine receptor agonists.
Review
2015
Review
2015
Possible neuroimmunomodulation therapy in T-cell-mediated oral diseases
Introduction: Recurrent aphthous stomatitis and oral lichen planus are local chronic inflammatory diseases which are implicated… 
2014
2014
Effects of systemically applied nAChRα7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythms
2014
2014
Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats
2014
2014
C including dopamine neuron degeneration , suggesting that the nicotine in tobacco may underlie the reduced incidence of Parkinson ' s disease in smokers (
25 26 27 28 29 30 31 32 33 34 35 36 Article history: Received 30 June 2014 Revised 5 September 2014 Accepted 16 September 2014… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)